Biotech Matthew Herper STAT Plus: Lilly’s Retevmo shows success in rare tumors. But can doctors identify the patients who would be helped?
Biotech Shafaq Zia STAT Plus: Antigen-based metric could better predict which patients benefit from immunotherapy, study says
Biotech Kate Sheridan STAT Plus: Startup Spotlight: Juno, Vir alum starts a new immunotherapy company
Politics Casey Ross STAT Plus: Medicare proposes a boost in payments for CAR-T and other breakthrough drugs and devices
First Opinion Doreen Carvajal Male doctors said my ‘female’ cancer was incurable. Then a woman took command and gave me hope
Health Bob Tedeschi For cancer patients, newest treatments force the ultimate decision, with no room for error
Biotech Damian Garde Novel cancer treatment from Kite Pharma notches positive results, but big questions remain
Biotech Sharon Begley Beware the hype: Top scientists cautious about fighting cancer with immunotherapy
In the Lab Sharon Begley In cancer, it’s back to the future as old treatments make cutting-edge ones more effective
Health Rebecca Robbins For cancer patients on experimental immunotherapy drugs, it’s been an emotional week
Biotech Damian Garde and Meghana Keshavan Juno halts its immunotherapy trial for cancer after three patient deaths